Career history of Elie K. Farah
Former positions of Elie K. Farah
Companies | Position | Start | End |
---|---|---|---|
MERUS LABS INTERNATIONAL INC | Director/Board Member | 2012-01-11 | 2014-09-22 |
Chief Executive Officer | 2012-01-11 | 2014-09-22 | |
President | 2012-01-11 | 2014-09-22 | |
TRANSITION THERAPEUTICS INC | Director of Finance/CFO | 2005-05-20 | 2011-02-08 |
Public Communications Contact | 2010-08-03 | 2011-02-08 | |
President | 2005-05-20 | 2011-02-08 | |
INVENTUS MINING CORP. | Director/Board Member | 2012-04-18 | - |
Independent Dir/Board Member | 2012-04-18 | - | |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - | - |
Pricewaterhouse & Co. | Corporate Officer/Principal | - | - |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Director of Finance/CFO | - | - |
Statistics
International
Canada | 5 |
United States | 2 |
Germany | 2 |
Operational
Director of Finance/CFO | 2 |
President | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 5 |
Commercial Services | 2 |
Non-Energy Minerals | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
INVENTUS MINING CORP. | Non-Energy Minerals |
Private companies | 5 |
---|---|
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Health Technology |
Transition Therapeutics, Inc.
Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
Pricewaterhouse & Co. | Commercial Services |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Merus Labs International, Inc.
Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and it was headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Elie K. Farah
- Experience